ℹ️
🇬🇧
Search
Search for people relevant for "In Vitro"
In Vitro
Person
Class
Person
Publication
Programmes
doc. PharmDr. Martin Štěrba Ph.D.
Academic staff at Faculty of Medicine in Hradec Králové
12 classes
127 publications
Classes
class
Pharmacology I
+3
FD10032 |
Faculty of Medicine in Hradec Králové
class
Pharmacology II
+3
FD10033 |
Faculty of Medicine in Hradec Králové
class
Clinical Pharmacology
+3
FD10073 |
Faculty of Medicine in Hradec Králové
Load more classes (2)
Publications
publication
In vivo and in vitro assessment of the role of glutathione antioxidant system in anthracycline-induced cardiotoxicity
2011 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
publication
Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo
+1
2008 |
Faculty of Medicine in Hradec Králové
publication
In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicity
+1
2007 |
Faculty of Medicine in Hradec Králové
publication
Cardiac troponin T as a biochemical marker of anthracycline-induced cardiotoxicity in vivo
+1
2007 |
Faculty of Medicine in Hradec Králové
publication
New iron chelators in anthracycline-induced cardiotoxicity
+1
2007 |
Faculty of Medicine in Hradec Králové
publication
Evaluation of in vitro protection by salicylaldehyde isonicotinoyl hydrazone (SIH) against hydrogen peroxide-and anthracycline-induced toxicity to cardiac cells
Publication without faculty affiliation
publication
Primary prevention of chronic anthracycline cardiotoxicity with ACE inhibitor is temporarily effective in rabbits, but benefits wane in post-treatment follow-up
2022 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
publication
Development of a Rat Model of Intra-Amniotic Inflammation via Ultrasound-Guided Administration of a Triggering Agent in the Gestational Sac to Enable Analysis of Individual Amniotic Fluid Samples
2022 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
publication
Structure-Activity Relationship Study of Dexrazoxane Analogues Reveals ICRF-193 as the Most Potent Bisdioxopiperazine against Anthracycline Toxicity to Cardiomyocytes Due to Its Strong Topoisomerase II beta Interactions
2021 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
publication
Prodrug of ICRF-193 provides promising protective effects against chronic anthracycline cardiotoxicity in a rabbit model in vivo
2021 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
Load more publications (117)
Loading network view...